Paul D. Rubin

Partner
Washington, D.C.
Tel: +1 202 383 8150
Overview
Paul D. Rubin is a corporate partner based in the Washington, D.C. office and is the Co-Chair of the firm’s Healthcare & Life Sciences Group ... Read Full Biography

Publications

Upcoming Events

Recent Events

  • FDA Regulation of OTC Drugs After the CARES Act: Opportunities for Innovation
    13 May 2020
    Debevoise & Plimpton LLP
    Webinar
    Speaking Engagements
  • FDA’s Response to the Novel Coronavirus: What Life Sciences Companies and Investors Need to Know
    9 April 2020
    Debevoise & Plimpton LLP
    Webinar
    Speaking Engagements
  • The SEC/FDA Nexus: Best Practices for Publicly Traded Life Sciences Companies
    20 February 2019
    Practicing Law Institute
    Practice Briefing
    Speaking Engagements
  • Medical Device Post-Market Cybersecurity – Stakeholder Interactions and the Importance of Advancing Coordinated Vulnerability Disclosure
    7 February 2019
    Practicing Law Institute
    Practice Briefing
    Speaking Engagements
  • Medical Device Cybersecurity
    20 November 2018
    Medical Device Innovation Consortium
    MDIC Webinar
    Webinar
    Speaking Engagements
  • Health Claims and the Interrelationship Between FDA, the FTC and NAD
    8 November 2018
    New York City Bar Association
    New York City Bar, Consumer Affairs Committee
    New York, New York
    Speaker: Paul D. Rubin
    Speaking Engagements
  • Medical Device Cybersecurity: Coordinated Vulnerability Disclosure
    5 September 2018
    Medical Device Innovation Consortium
    2018 Annual Public Forum 2018 MDIC Annual Public Forum
    Washington, DC
    Speaking Engagements
  • Dietary Supplements
    18 June 2018
    American Conference Institute & Council for Responsible Nutrition
    ACI-CRN Dietary Supplements Conference
    New York, New York
    Speaker: Paul D. Rubin
    Speaking Engagements